011040 — Kyung Dong Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual income statement for Kyung Dong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	173,828	177,611	182,718	162,674	193,936
Cost of Revenue
Gross Profit	98,608	97,170	94,994	88,306	113,663
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	154,877	161,855	174,906	187,347	191,430
Operating Profit	18,950	15,755	7,812	-24,673	2,506
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	19,339	18,432	17,941	-18,503	5,221
Provision for Income Taxes
Net Income After Taxes	12,873	12,627	12,113	-20,730	5,448
Minority Interest
Net Income Before Extraordinary Items
Net Income	12,459	12,672	12,161	-20,708	5,470
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12,459	12,672	12,161	-20,708	5,470
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	507	459	463	-771	203
Dividends per Share